Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
Abroad (travel likely)RecruitingPHASE2
Conditions
Melanoma · Non Small Cell Lung Cancer · Cervical Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vall d'Hebron Institute of Oncology, Barcelona, Spain
Contact: Principal Investigator (Elena Garralda, MD)Vladimir Galvão de Aguiar, MD (Sub-investigator)
Study leads
Elena Garralda
Principal Investigator
Vall d'Hebron Institute of Oncology